Benzinga's Top Pre-Market Losers
Vical (NASDAQ: VICL) dipped 62.01% to $1.36 in the pre-market session after drug trial failure.
Tesla Motors (NASDAQ: TSLA) dipped 2.47% to $149.22 in the pre-market session after Lazard Capital Markets downgraded the stock from “buy” to “neutral.”
Partner Communications Company (NASDAQ: PTNR) shares fell 2.12% to $7.39 in the pre-market trading. Partner Communications is expected report its reviewed financial results for the second quarter on August 28, 2013.
Broadcom (NASDAQ: BRCM) shares dropped 1.57% to $25.65 in pre-market trading after Goldman Sachs downgraded the stock from “buy” to “neutral.”
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.